Savvy Updates 5/1/23:  Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?

Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?

Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023.   Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...
Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?

Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?

Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet by Liam Davenport for MedScape.com, 14 April 2023.   ChatGPT, the novel artificial intelligence (AI) tool that has attracted interest and controversy in seemingly equal measure, can provide clear and...
Savvy Updates 4/10/23:  Abbott FreeStyle Libre Class 1 Recall, 2 T Cell Populations, Gut Health on TikTok, Pancreatic Endocrine & Exocrine Cells, “Counting Carbs is a Crapshoot!”

Savvy Updates 4/10/23: Abbott FreeStyle Libre Class 1 Recall, 2 T Cell Populations, Gut Health on TikTok, Pancreatic Endocrine & Exocrine Cells, “Counting Carbs is a Crapshoot!”

Abbott faces Class I recall of 4.2M glucose readers on battery fire risks by Peter Green for MedTechDive.com, 6 April 2023. Abbott has initiated a recall for readers for its FreeStyle Libre glucose monitoring systems, which are at risk of catching fire if improperly...
Savvy Updates, 4/3/23: Glucose-run Fuel Cell to Power Insulin Release, Inreda Diabetic AP Coming to Market 2024, Biomea Fusion BMF-219 May Preserve Beta Cells, Bigfoot Biomedical Buys Insulin Titration Algorithm, Verapamil Preserves C-Peptide Levels, OOP Cost of Diabetes Medications, PBMs Under Scrutiny, Splenda® Stevia Farm

Savvy Updates, 4/3/23: Glucose-run Fuel Cell to Power Insulin Release, Inreda Diabetic AP Coming to Market 2024, Biomea Fusion BMF-219 May Preserve Beta Cells, Bigfoot Biomedical Buys Insulin Titration Algorithm, Verapamil Preserves C-Peptide Levels, OOP Cost of Diabetes Medications, PBMs Under Scrutiny, Splenda® Stevia Farm

Scientists use implanted glucose-run fuel cell to power insulin release by Nick Paul Taylor for MedTechDive.com, 29 March 2023.   There is a need for better ways to power medical implants. Devices either have a battery that gradually runs down and...
Savvy Update, 3/27/23: Non-Invasive Monitoring: Know Labs & Hagar’s GWave, California’s Brand of Insulin, Steatosis in Adult T1Ds, MDs Leaving Their Jobs, Colorectal Cancers in Adult T1Ds, Off-Label Prescribing

Savvy Update, 3/27/23: Non-Invasive Monitoring: Know Labs & Hagar’s GWave, California’s Brand of Insulin, Steatosis in Adult T1Ds, MDs Leaving Their Jobs, Colorectal Cancers in Adult T1Ds, Off-Label Prescribing

Know Labs establishes scientific advisory board to advance non-invasive glucose monitoring by Sean Whooley for DrugDeliveryBusiness.com, 22 March 2023. Know Labs announced that it established a scientific advisory board to accelerate the development of its glucose...
Skip to content